Literature DB >> 8514304

Substance abuse and onset of psychotic illness.

B Kovasznay1, E Bromet, J E Schwartz, R Ram, J Lavelle, L Brandon.   

Abstract

OBJECTIVE: This study examined the relationship of substance abuse history to psychotic diagnosis and clinical presentation in a sample of 188 subjects with newly diagnosed psychotic illness.
METHODS: Subjects were assessed using a structured diagnostic interview and clinical rating scales. The diagnosis and demographic and clinical characteristics of subjects with a substance abuse history were compared with those of subjects without a substance abuse history. Data for males and females were considered separately in most analyses.
RESULTS: Substance abuse history was unrelated to initial diagnosis, age at onset of psychotic symptoms, ratings of best and worst levels of functioning, or severity of positive symptoms. Substance abuse was significantly associated with higher anxiety and depression scores on the Brief Psychiatric Rating Scale. Males without substance abuse had more negative symptoms and were less likely to have attempted suicide than males with substance abuse.
CONCLUSIONS: Substance abuse appears to have limited influence on the clinical presentation of non-substance-induced psychotic disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514304     DOI: 10.1176/ps.44.6.567

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  7 in total

1.  Correlates of functioning in a population with dual diagnoses: an examination of diagnosis and problem history.

Authors:  L C Jordan; D A Luke; C T Mowbray; S E Herman; W S Davidson; C Conklin
Journal:  J Ment Health Adm       Date:  1996

2.  Predictors of psychosis remission in psychotic disorders that co-occur with substance use.

Authors:  Carol L M Caton; Deborah S Hasin; Patrick E Shrout; Robert E Drake; Boanerges Dominguez; Sharon Samet; Bella Schanzer
Journal:  Schizophr Bull       Date:  2006-07-27       Impact factor: 9.306

3.  The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats.

Authors:  Marco Bortolato; Gian Nicola Aru; Roberto Frau; Marco Orrù; Grant Christopher Luckey; Gianluca Boi; Gian Luigi Gessa
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

4.  Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders.

Authors:  Kelly Jarvis; Melissa P DelBello; Neil Mills; Igor Elman; Stephen M Strakowski; Caleb M Adler
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-12       Impact factor: 2.576

5.  Substance abuse in first-episode schizophrenic patients: a retrospective study.

Authors:  M C Mauri; L S Volonteri; I F De Gaspari; A Colasanti; M A Brambilla; L Cerruti
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-03-23

6.  A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches.

Authors:  Samuel Sarrazin; Florence Louppe; Raphael Doukhan; Franck Schürhoff
Journal:  Ann Gen Psychiatry       Date:  2015-12-10       Impact factor: 3.455

7.  The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.

Authors:  Else-Marie Løberg; Siri Helle; Merethe Nygård; Jan Øystein Berle; Rune A Kroken; Erik Johnsen
Journal:  Front Psychiatry       Date:  2014-11-18       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.